Here comes the oral GLP-1 drug for di­a­betes — but No­vo Nordisk is­n't dis­clos­ing Ry­bel­sus price just yet

Yesterday
Pharma
R&D

Astel­las/Fi­bro­Gen's ane­mia drug for CKD pa­tients ap­proved in Japan; Re­searchers pro­pose com­bo to stay ahead of KRAS re­sis­tance

Yesterday
Protocols

Astel­las' AML drug wins over CHMP — strength­en­ing lead on Dai­ichi Sankyo

Yesterday
Pharma

In­trex­on unit push­es back against claims its GM mos­qui­toes are mak­ing dis­ease-friend­ly mu­tants

Yesterday
R&D
Regulatory

Chris Roberts jumps back in­to biotech with CSO gig at Black Di­a­mond; Trou­bled Five Prime ap­points in­ter­im CEO

Yesterday
Peer Review

Pur­due threat­ens to walk away from set­tle­ment, asks to pay em­ploy­ees mil­lions in bonus­es

Yesterday
Pharma

Boehringer In­gel­heim en­lists an­oth­er vir­tu­al biotech part­ner for its for­ay in­to reti­nal dis­eases

Yesterday
Deals

Genen­tech sub­mits a big plan to ex­pand its South San Fran­cis­co foot­print

Yesterday
Pharma
R&D

As Nas­daq en­rolls the fi­nal batch of 2019 IPOs, how have the num­bers com­pared to past years?

Yesterday
IPOs

Em­maus re­scinds EU mar­ket­ing ap­pli­ca­tion, fol­low­ing neg­a­tive re­view

Yesterday
Pharma
Regulatory

While No­var­tis ban­ish­es Zol­gens­ma scan­dal scars — Bio­gen goes on a Spin­raza 'of­fen­sive'

2 days ago
Pharma
R&D

Eye­ing big ther­a­peu­tic push, Gink­go bags $290M to build a cell pro­gram­ming em­pire

2 days ago
Venture

UP­DAT­ED: Speak­er Nan­cy Pelosi to un­veil bill for fed­er­al­ly ne­go­ti­at­ed drug prices

2 days ago
People
Pharma

Alzheimer’s re­search in line for $350M boost as Sen­ate pro­pos­es $3B hike to NIH bud­get; Al­lo­gene teams up with Stan­ford re­searchers

2 days ago
Protocols

Can­cer tri­als aimed at 'sur­ro­gate' tar­gets miss big­ger mark — study

2 days ago
R&D

Zol­gens­ma did­n't cause an in­fant death, AveX­is ex­ecs say as they spot­light long-term da­ta

2 days ago
Cell/Gene Tx
Pharma

Jeff Kindler's Cen­trex­ion re­news bid to make pub­lic de­but

2 days ago
IPOs
Startups

'A fourth rev­o­lu­tion in can­cer ther­a­pies': ARCH-backed Bound­less Bio flash­es big check, makes big­ger promis­es in de­but

2 days ago
Startups
Venture

Biotech boards bur­dened: Bridg­ing the suc­cess gap

3 days ago
Biotech Voices
IPOs

FDA lays out tech mod­ern­iza­tion ac­tion plan

3 days ago
Regulatory

'Dis­con­nect the bas­tard­s' — one biotech's plan to break can­cer cell­s' uni­fied de­fens­es

3 days ago
Cell/Gene Tx
R&D

Sen­a­tors to FTC: Don't let the big Cel­gene and Al­ler­gan buy­outs hurt R&D and con­sumers

3 days ago
People
Pharma

Young an­ti-ag­ing field takes big step with Mayo Clin­ic senolyt­ics show­case

3 days ago
R&D

vTv Ther­a­peu­tics re­ports ad­di­tion­al pos­i­tive PhII da­ta; Shang­hai Hen­lius prices $410 mil­lion IPO at bot­tom of range

3 days ago
Protocols
1234 Next page Last page